Take a trial of UK to unlock this pageFind out more
© Stockopedia 24th January, 2018


AVCT 66.5p 0.0  0.0%
23/01/18 1.50k

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Jul 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p -4.0%

FINANCIAL BRIEF: For the fiscal year ended 31 July 2017, Avacta Group Plc revenues increased 26% to £2.7M. Net loss increased 37% to £6.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Administrative expenses increase of 32% to £7.2M (expense), Research and development costs increase of 73% to £2.6M (expense), Financial income decrease of 11% to £88K (income). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Jul '17) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Jul 2018
31st Jul 2019

Price Target: 1.80
(+176.91% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
2 brokers Broker Consensus Trend
Broker Recommendations for Avacta
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
Panmure Gordon , Hardman & Company Martin Hall , Numis Securities Sally Taylor , Edison Investment Research , FinnCap Mark Brewer ,

Profile Summary

Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.

Directors: Alastair Smith (CEO) , Tony Gardiner (CFO) 44, Trevor Nicholls (NEC) 58, Michael Albin (NED) , Gwyn Humphreys (NED) , Michael Owen (NED) 64, Alan Aubrey (NID) 55,

No. of Employees: 103 No. of Shareholders: n/a

Last Annual July 31st, 2017
Last Interim July 31st, 2017
Incorporated April 29, 2003
Public Since September 8, 2003
Shares in Issue 68,973,337
Free Float 60.7m (88.0%)
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

AVCT Share Price Performance AVCTQuote
0.0  0.0%
Traded 12:00am · Minimum 15 min delayed · NMS: 1.50k

Latest AVCT News Announcements (delayed)

Upcoming AVCT Events
Monday 2nd April, 2018 (estimate)
Half Year 2018 Avacta Group PLC Earnings Release

Recent ↓
Thursday 18th January, 2018
Avacta Group PLC Annual Shareholders Meeting
Monday 4th December, 2017
Q4 2017 Avacta Group PLC Earnings Release
Wednesday 4th October, 2017
Preliminary Q4 2017 Avacta Group PLC Earnings Release
Monday 3rd April, 2017
Half Year 2017 Avacta Group PLC Earnings Release
Monday 17th October, 2016
Full Year 2016 Avacta Group PLC Earnings Release
Thursday 23rd June, 2016
Avacta Group PLC at Berenberg Discovery Conference
Monday 25th April, 2016
Half Year 2016 Avacta Group PLC Earnings Release
Tuesday 26th January, 2016
Avacta Group PLC Reverse Split For AVCT.L
Wednesday 15th July, 2015
Avacta Group PLC Secondary Public Offering Filing

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.

Should you buy AVCT

Access AVCT Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis